To determine whether CD93 is coexpressed with MMRN2 and fibronectin fibrils in human glioma vessels, we analyzed the fraction of blood vessels positive for MMRN2 (Figure 9A) and fibronectin (Figure 9B) in glioma tissue microarrays, containing a total of 235 samples of human control brain and WHO grade II–IV glioma tissues, and correlated the scores with our previous scoring of CD93 expression (11). The gene discussed is CD93; the disease is central nervous system cancer.